BASF's Revenue Jump Masks a Thinner Bottom Line as Jefferies Turns Bearish

BASF posted third-quarter 2026 sales of EUR 16.36 billion, a 14.18% advance on the year-earlier period — but the gain did not carry through to per-share earnings, which slipped to EUR 0.18 from EUR 0.19. That divergence sits at the heart of the debate now swirling around the chemicals maker, and it explains why Jefferies analyst Priyanka Patel has moved to a more defensive stance.

Patel cut her rating on BASF to "Underperform" from "Hold" while keeping her price target at EUR 44. The downgrade, paired with an unchanged target, signals that the brokerage's caution has deepened even though its valuation floor has not moved.

Overcapacity, gas costs and a demand gap

Her case rests on three pressures arriving at once. Patel expects overcapacity to persist — and to stretch into the new year — making any margin recovery harder to achieve. Higher gas prices add a cost headwind on top. Meanwhile, she sees no pickup in demand that might offset either burden.

The energy backdrop gives that warning extra weight. European gas prices recently climbed above EUR 100 per megawatt-hour for the first time since the 2022 energy crisis, according to a Bloomberg report. For a company as energy-intensive as BASF, that threshold matters.

Translating those assumptions into numbers, Patel's operating earnings forecast for 2027 lands 5% below the analyst consensus. The implication is blunt: the earnings recovery the market has been pricing in may prove weaker than expected.

A divided analyst community

Consensus is far from settled. Of 25 analysts covering the stock, ten recommend buying. Nine sit on hold or neutral ratings, and six lean negative. The spread underscores how differently the market reads BASF's path from here.

What would shift the picture? A demand upswing, or relief on the margin and cost side, would justify a more constructive view. Absent that, Patel's caution carries more force — particularly if other analysts begin trimming their own earnings estimates.

The test ahead

The next scheduled checkpoint is fourth-quarter 2026 results on 26 February 2027. Investors will be watching whether BASF can convert its top-line growth into stronger profitability. If margins stay compressed and demand stays soft, the earnings risk Patel has flagged will move to the center of the investment case. If the extra revenue starts flowing through to the bottom line, the skeptics will have some explaining to do.